BioForce Nanosciences Holdings Inc (OTC: BFNH) is a nutrition supplement company that markets a single powdered multivitamin and mineral product called BioForce Eclipse. The company's intended revenue model is transactional sales of the Eclipse supplement through retailers, sporting goods stores, supermarkets, mass merchandisers, and online channels, though the company recorded $0 in revenue for both fiscal years ended December 31, 2025 and December 31, 2024, with zero units sold in either period. BFNH operates from an executive office in Virginia Beach, Virginia, and private labels the Eclipse powder through a Virginia-based manufacturer under a supplier agreement that grants non-exclusive marketing rights, with the formula owned by the distributor. The company carries a going concern qualification from its auditors as of the fiscal year ended December 31, 2025, has not achieved profitability, and relies on equity or debt offerings to fund operations. No dividends have been declared or paid on common stock.

Revenue model

Transactional retail and B2B sales of the BioForce Eclipse powdered supplement, targeting retailers, pharmacies, sporting goods stores, and online platforms. The company recorded $0 in revenue for fiscal years ended December 31, 2025 and December 31, 2024.

Products and services

BioForce Eclipse: a private-label powdered multivitamin and mineral supplement. The product is manufactured and custom-labeled by a Virginia-based third-party distributor under consignment terms, meaning BFNH pays only upon sale.

Customers and end markets

Intended customers include health-conscious consumers, retailers, health food stores, sporting goods retailers, supermarkets, mass merchandisers, and online stores. No sales to any customers were recorded in fiscal years 2024 or 2025.

Value-chain role

BFNH operates as a marketing and distribution company. It does not own the product formula. A Virginia-based third-party manufacturer produces, labels, and packages the Eclipse powder under a non-exclusive supplier agreement with consignment terms.

Geographic exposure

Operations headquartered in Virginia Beach, Virginia. The company targets the United States market exclusively, per the 10-K filed April 15, 2026.

Source: SEC 10-K, filed 2026-04-15

Industry: Laboratory Analytical Instruments Peers: LFTD Partners Inc FitLife Brands Inc Estee Lauder Companies Inc Upexi, Inc Healing Co Inc. Nature's Sunshine Products Inc REVLON INC /DE/ Thorne Healthtech, Inc.